In addition, recent evidence, based on genome-wide association studies (GWAS) analysis, revealed that increased levels of cathepsin B are associated with lower PD risk, whereas no significant associations were found for cathepsin E, F, G, H, L1, L2, O, S, and Z [27,35]. Here, CTSB is linked to Parkinson disease.